avapro has been researched along with Neurally Mediated Faint in 1 studies
Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, Y | 1 |
| Lü, XY | 1 |
| Jiang, WL | 1 |
| Yang, YM | 1 |
| Chen, TZ | 1 |
1 other study available for avapro and Neurally Mediated Faint
| Article | Year |
|---|---|
Clinical observation of irbesartan in treatment of vasovagal syncope.
Topics: Adult; Aged; Angiotensin II Type 2 Receptor Blockers; Biphenyl Compounds; Blood Pressure; Female; He | 2005 |